Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Sitafloxacin
Introduction
Overview
Overview
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.
References
References
- β Anderson, DL. (Jul 2008). “Sitafloxacin hydrate for bacterial infections”. Drugs Today (Barc). 44 (7): 489β501. doi:10.1358/dot.2008.44.7.1219561. PMIDΒ 18806900.
Further reading
Further reading
- Keating GM (April 2011). “Sitafloxacin: in bacterial infections”. Drugs. 71 (6): 731β44. doi:10.2165/11207380-000000000-00000. PMIDΒ 21504249.
External links
External links
- Template:Ja icon Gracevit γ°γ¬γΌγΉγγγ (PDF) Daiichi Sankyo Co. January 2008.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]